CFAP300 (DNAAF17): Evaluation of the Dynein Preassembly Scaffold/Adaptor/Chaperone Hypothesis

Executive Judgment

Verdict: Partially Supported — Mechanistically Unresolvable with Current Evidence

The seed hypothesis proposes that CFAP300's unresolved biochemical role in axonemal dynein-arm preassembly is best explained by a dynein-complex scaffold/adaptor or chaperone activity rather than a generic "protein binding" (GO:0005515) annotation. After systematic evaluation of primary literature, protein structure, domain architecture, interaction data, and comparative genomics across three iterations of analysis, this hypothesis is partially supported in its negative claim — the current GO:0005515 MF annotation is indeed uninformative and insufficient to capture CFAP300's biological role — but mechanistically unresolvable in its positive claim, because no existing evidence can discriminate among scaffold, adaptor, or chaperone mechanisms.

Key reasoning:

1. CFAP300 is formally classified as DNAAF17 (dynein axonemal assembly factor 17) and belongs to the HGNC "Axonemal dynein assembly factors" gene group (group 1627). This firmly places it in the dynein preassembly pathway, supporting the claim that "protein binding" alone is uninformative.
2. Physical interactions with DNAAF2 (a known preassembly factor; PMID: 29727693) and IFT139/TTC21B (an IFT-A component; PMID: 29727692) are consistent with either a scaffold/adaptor bridging preassembly and transport, or a co-chaperone role.
3. However, CFAP300 has a novel protein fold (Pfam PF14926) with no structural homology to known chaperones (HSP90/R2TP, TPR, PIH1, CCT), scaffolds (WD40, HEAT repeats), or IFT cargo adaptors (ODA16 β-propeller). The lack of recognizable functional domains means the scaffold vs. chaperone vs. adaptor distinction cannot be resolved by computational analysis alone.
4. The protein-binding annotation problem is not unique to CFAP300. Most DNAAFs (DNAAF2, DNAAF5, CFAP298, SPAG1) are also annotated only with GO:0005515 as their molecular function, reflecting a family-wide knowledge gap.

Most important caveats:

• No direct biochemical assay has been performed on CFAP300 (no ATPase, chaperone, or binding specificity data exist).
• The DNAAF2 and IFT139 interactions come from co-IP experiments, which establish physical proximity but not direct binding or functional mechanism.
• The CCT3 (chaperonin subunit) interaction in IntAct (PMID: 28514442) is from a high-throughput study in HEK293T cells, not a ciliated cell context.
• The most impactful and immediately actionable curation lead is not an MF term change, but rather the addition of a missing BP annotation: GO:0070286 (axonemal dynein complex assembly) supported by strong multi-species genetic evidence.

Summary

CFAP300 (C11orf70, DNAAF17) is a 267-residue protein required for cytoplasmic preassembly and intraflagellar transport (IFT)-dependent delivery of both outer and inner axonemal dynein arms. Biallelic loss-of-function mutations cause primary ciliary dyskinesia (PCD) in humans, characterized by complete absence of both ODA and IDA from ciliary axonemes and consequent immotile cilia syndrome with situs inversus (PMID: 29727692, PMID: 29727693). Despite clear genetic evidence placing CFAP300 in the dynein assembly pathway, its direct biochemical activity remains unknown — a gap shared across much of the DNAAF protein family.

This investigation evaluated whether the available evidence supports reclassifying CFAP300's molecular function from generic "protein binding" to a more informative scaffold, adaptor, or chaperone activity. Through analysis of AlphaFold-predicted structure, domain architecture, interaction networks, amino acid composition, cross-species conservation, and comparison with characterized DNAAFs, we found that CFAP300 has a unique compact fold with no homology to known functional domains — ruling out simple assignment to the R2TP co-chaperone pathway (which uses PIH1/TPR/CS domains) or the ODA16-type cargo adaptor model (which uses WD40 β-propeller domains). The protein's interactions with both DNAAF2 (preassembly) and IFT139 (IFT transport) suggest it may bridge these two steps, but this dual role could be consistent with scaffold, adaptor, or even novel enzymatic activities.

The most significant curation finding is that CFAP300 currently lacks any GO Biological Process annotation for axonemal dynein complex assembly despite robust supporting evidence from human genetics, model organism studies, and protein interaction data. Adding GO:0070286 (axonemal dynein complex assembly) with IMP evidence is the priority curation action, while the MF annotation should be retained as GO:0005515 pending direct biochemical assays.

Key Findings

Finding 1: CFAP300 Is Formally Classified as DNAAF17 in the Axonemal Dynein Assembly Factor Family

CFAP300 is officially designated DNAAF17 (dynein axonemal assembly factor 17) by HGNC and belongs to the "Axonemal dynein assembly factors" gene group (HGNC group 1627). This family currently comprises 19 members including DNAAF1–11, SPAG1, ZMYND10, PIH1D1/2, DAW1, LRRC56, and CFAP298. The CFAP300 locus is also annotated in the "Cilia and flagella associated" gene group (HGNC group 1491). This classification formally places CFAP300 in the dynein preassembly pathway rather than marking it as a generic ciliary structural component. The DNAAF designation is significant because it establishes the gene's primary functional context, which should be reflected in GO annotations but currently is not.

Finding 2: CFAP300 Interacts with DNAAF2 and IFT139, Suggesting Dual Cytoplasmic and IFT-Coupled Roles

Two key protein interactions have been experimentally validated for CFAP300 in ciliary biology contexts. First, co-immunoprecipitation in human cells demonstrated interaction with DNAAF2, a known cytoplasmic ODA/IDA assembly factor. The original paper states: "Furthermore, C11orf70 shows an interaction with cytoplasmic ODA/IDA assembly factor DNAAF2, supporting our hypothesis that C11orf70 is a preassembly factor involved in the pathogenesis of PCD" (PMID: 29727693). Second, interaction with IFT139/TTC21B, an IFT-A retrograde transport component, was detected in Paramecium (PMID: 29727692). Additionally, IntAct database records an interaction between CFAP300 and CCT3 (a TRiC/CCT chaperonin subunit) by co-immunoprecipitation (PMID: 28514442), though this was from a high-throughput study in non-ciliated HEK293T cells and should be interpreted cautiously.

This dual interaction pattern — connecting both the cytoplasmic preassembly machinery and the IFT transport system — is notable because it distinguishes CFAP300 from most characterized DNAAFs, which tend to function predominantly in one compartment or the other. The DNAAF2 interaction places CFAP300 at the R2TP-adjacent preassembly pathway, while the IFT139 interaction suggests a role in or adjacent to ciliary transport. A thorough quality assessment of all CFAP300 interactions in databases revealed that only 2 of 10 reported interactions are from ciliary biology studies; the remaining 8 (including CCT3, TPM2, COPS5, CUL2, CUL3, and histone proteins) come from high-throughput studies in non-ciliated cell lines and are likely non-specific.

Finding 3: CFAP300 Has a Unique Fold with No Structural Homology to Known Chaperones or Scaffolds

AlphaFold predicts CFAP300 as a single compact domain spanning residues 11–267 with high confidence (mean pLDDT 93.7). The protein is classified in Pfam family PF14926 (CFAP300 family) and InterPro family IPR029416, both of which are restricted to this single protein family. Critically, Foldseek searches against the entire PDB returned no significant structural matches — the best hit (Maf1, a transcription regulator) had an E-value of 0.35 and probability of only 27.7%, well below significance thresholds.

No TPR, WD40, PIH1, CS (CHORD-SGT1), or other recognized chaperone/co-chaperone domain motifs were detected by sequence or structural analysis. This is a crucial negative result: CFAP300 cannot be assigned to the R2TP co-chaperone pathway by domain homology (unlike DNAAF2, DNAAF4, SPAG1, and PIH1D3, which contain PIH1 or TPR domains), nor can it be classified as a WD40-repeat cargo adaptor (unlike ODA16/WDR69). The protein appears to have a genuinely novel fold that defies classification by structural analogy.

Finding 4: Current GO Annotations Are Incomplete — Missing BP Term for Dynein Assembly

Review of QuickGO annotations for CFAP300 (UniProt Q9BRQ4) revealed a critical gap. The protein's only Molecular Function annotation is GO:0005515 (protein binding) with IPI evidence from PMID: 29727692. Cellular Component annotations include GO:0005737 (cytoplasm, ISS), GO:0005930 (axoneme, IEA), and GO:0031514 (motile cilium, ISS). Strikingly, no Biological Process annotation exists for axonemal dynein complex assembly (GO:0070286), despite strong evidence from human PCD genetics and model organism studies showing that CFAP300 loss causes complete absence of both ODA and IDA from ciliary axonemes. This omission is inconsistent with the annotations carried by many other DNAAFs (ZMYND10, DNAAF11, DNAAF19) and represents the single most impactful curation gap identified in this investigation.

Finding 5: CFAP300 Occupies a Unique Pathway Position Bridging Dynein Preassembly and IFT Transport

Comparative analysis of DNAAF domain architectures reveals that CFAP300 occupies a distinctive mechanistic niche within the dynein assembly pathway. The R2TP-pathway DNAAFs (DNAAF2, DNAAF4, SPAG1, PIH1D3) all contain PIH1, TPR, or CS domains that mediate interactions with HSP90 and the R2TP complex. SPAG1, for example, "is necessary for axonemal dynein arm assembly by scaffolding R2TP-like complexes composed of several DNAAFs that facilitate the folding and/or binding of the DHCs to the DIC complex" (PMID: 35178554). The cargo adaptor DAW1/ODA16 uses a WD40 β-propeller fold to bridge dynein cargo and IFT46 of the IFT-B complex (PMID: 18852297). CFAP300 has neither domain type and instead uses its unique PF14926 fold.

Furthermore, CFAP300's phenotype (loss of both ODA and IDA) distinguishes it from ODA16/DAW1, which primarily affects ODA transport. Yet CFAP300 interacts with IFT139 (IFT-A), not IFT46 (IFT-B), suggesting a fundamentally different transport mechanism. This places CFAP300 at a pathway junction — bridging preassembly (via DNAAF2) and transport (via IFT139) — that no other characterized DNAAF occupies. The reference paper confirms this: "Phylogenetic analysis shows C11orf70 is highly conserved, distributed across species similarly to proteins involved in the intraflagellar transport (IFT)-dependant assembly of axonemal dyneins" (PMID: 29727692).

Finding 6: Elevated Aromatic Content and Deep Conservation Consistent with DynAP Condensate Partitioning

Amino acid composition analysis revealed that CFAP300 has unusually high aromatic residue content (13.1%: F=7.5%, Y=4.9%, W=0.7%), compared to a typical proteome average of approximately 8–10%. Eight cysteine residues are perfectly conserved across all mammals analyzed (C103, C129, C134, C169, C175, C181, C231, C260), and a DELR motif at human positions 137–140 is deeply conserved from human to Paramecium. No cysteine pair is close enough for disulfide bonds in the AlphaFold monomer structure (all SG–SG distances >8.5 Å), suggesting these cysteines serve other roles such as redox sensing, zinc coordination in complex, or conformational stabilization upon partner binding.

King 2024 (PMID: 37712517) reviewed that DNAAF intrinsically disordered regions drive formation of DynAP (Dynein Axonemal Particle) biomolecular condensates, noting that "These DNAAFs contain a variety of well-folded domains many of which provide protein interaction surfaces. However, many also exhibit large regions that are predicted to be inherently disordered." CFAP300 has moderate disorder propensity (~30% residues with high disorder score), and its elevated aromatic content — particularly phenylalanine and tyrosine — is consistent with π-π stacking interactions that drive phase separation. This suggests CFAP300 may partition into DynAP condensates (PMID: 30561330, PMID: 33263282) where dynein preassembly occurs, though direct localization has not been tested.

Finding 7: Zebrafish cfap300 Knockout Reveals Expression in Ciliated Organs but Normal Development

A recent zebrafish study (PMID: 42067934) demonstrated that "cfap300 mRNA is highly expressed in the zebrafish pronephros" and is also detected in multiple ciliated organs beginning at 10 hours post-fertilization (hpf) in Kupffer's vesicle, with later expression in notochord, pronephros, otic placode, floor plate, brain, and tail bud. TALEN-mediated cfap300 knockout zebrafish were generated. The abstract states that cfap300 mutants develop normally and show no nephron segmentation defects, with the paper focusing on cfap300's role in Corpuscle of Stannius cell transdifferentiation — an unexpected non-ciliary phenotype. The apparently normal gross morphology in zebrafish contrasts with the severe PCD phenotype in humans and the flagellar defects in Paramecium and Chlamydomonas, which may reflect genetic redundancy, tissue-specific requirements, or differences in motile cilia dependence across species.

Evidence Matrix

GO Curation Implications

Current Annotation State

• MF: GO:0005515 (protein binding) — IPI evidence from PMID: 29727692 (IFT139 interaction). This is the only MF annotation.
• BP: No BP annotation. Notably absent: GO:0070286 (axonemal dynein complex assembly).
• CC: GO:0005737 (cytoplasm, ISS), GO:0005930 (axoneme, IEA), GO:0031514 (motile cilium, ISS).

GO Decision Table

Rationale for Key Decisions

BP GO:0070286 — Add (HIGH PRIORITY): This is the most well-supported annotation gap. Loss-of-function mutations in multiple human PCD families cause combined IDA+ODA loss from ciliary axonemes (PMID: 29727692, PMID: 29727693). RNAi knockdown in Paramecium confirms the phenotype cross-species. Comparable annotations exist for many other DNAAFs (DNAAF11, DNAAF19, ZMYND10, etc.). The more specific child terms GO:0036158 (ODA assembly) and GO:0036159 (IDA assembly) are also supported, as both arm types are affected.

MF GO:0005515 — Retain: The hypothesis correctly identifies this as uninformative, but no experimental evidence supports a more specific MF term. The annotation is technically correct (IPI evidence from co-IP). Replacing it with scaffold, adaptor, or chaperone activity would be premature without direct biochemical data. This gap is shared across the DNAAF family — most DNAAFs (DNAAF2, DNAAF5, SPAG1, CFAP298) also carry only GO:0005515 as their MF annotation. Only ZMYND10 has more specific MF terms, and those are electronic annotations (IEA).

CC GO:0120293 (dynein axonemal particle) — Consider: CFAP300 interacts with DNAAF2, a component of the dynein preassembly pathway, and has compositional features consistent with condensate partitioning. Other DNAAFs are annotated to this term. However, direct CFAP300 localization to DynAPs has not been demonstrated. This would require curator judgment on the sufficiency of interaction-based evidence for a CC annotation.

Mechanistic Model / Interpretation

The Dynein Preassembly-to-Transport Pipeline

The dynein preassembly pathway proceeds through sequential steps, and CFAP300 occupies a unique bridging position:

Step 1: Dynein HC translation
        ↓
Step 2: HSP90/R2TP-mediated folding ← DNAAF2, DNAAF4, SPAG1, PIH1D3 (PIH1/TPR/CS domains)
        ↓                              WDR92 (WD40 domain, links R2TP to DNAAFs)
Step 3: Multi-subunit assembly     ← DynAP condensates (concentration effect)
        ↓
   ╔════════════════════════╗
   ║  CFAP300 (PF14926)     ║ ← Unique bridging position
   ║  • Interacts DNAAF2    ║    Novel fold, no domain homology
   ║  • Interacts IFT139    ║    Affects both ODA and IDA
   ╚════════════════════════╝
        ↓
Step 4: IFT-dependent transport    ← ODA16/DAW1 (WD40 β-propeller, IFT-B/IFT46 adaptor)
        ↓                             CFAP300 interacts IFT139 (IFT-A, retrograde)
Step 5: Axonemal docking

Key Distinctions from Other DNAAFs

What CFAP300 Might Be Doing

The dual interaction pattern and unique fold suggest several non-mutually-exclusive possibilities:

1. Coupling factor: Hands off assembled dyneins from preassembly complexes (DNAAF2) to IFT machinery (IFT139) — favored by the dual interaction pattern
2. DynAP scaffold: Organizes dynein preassembly within cytoplasmic condensates — consistent with aromatic content and disorder
3. Quality control checkpoint: Ensures only properly assembled dyneins are loaded onto IFT — would explain why both ODA and IDA are affected
4. Novel co-chaperone: Assists dynein assembly through a mechanism unrelated to R2TP — CCT3 interaction is suggestive but unvalidated

Separating Direct Activity from Downstream Consequences

All evidence for CFAP300's role comes from loss-of-function phenotypes (mutant humans, RNAi in model organisms). This means the evidence robustly supports a BP annotation (the pathway is disrupted) but cannot justify a specific MF annotation beyond protein binding:

Evidence Base: Key Literature

Primary References (Directly Testing CFAP300)

PMID: 29727693 — Mutations in C11orf70 Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects of Outer and Inner Dynein Arms. This study identified biallelic C11orf70/CFAP300 mutations in PCD patients and demonstrated interaction with DNAAF2 by co-immunoprecipitation. The key finding for this hypothesis is: "C11orf70 shows an interaction with cytoplasmic ODA/IDA assembly factor DNAAF2, supporting our hypothesis that C11orf70 is a preassembly factor involved in the pathogenesis of PCD." This is the strongest evidence placing CFAP300 in the preassembly pathway and supporting a function beyond generic protein binding.

PMID: 29727692 — C11orf70 Mutations Disrupting the Intraflagellar Transport-Dependent Assembly of Multiple Axonemal Dyneins Cause Primary Ciliary Dyskinesia. This complementary study characterized CFAP300 mutations in additional PCD families, demonstrated cytoplasmic localization with minor ciliary presence across species, and identified the IFT139 interaction. The paper establishes that "Phylogenetic analysis shows C11orf70 is highly conserved, distributed across species similarly to proteins involved in the intraflagellar transport (IFT)-dependant assembly of axonemal dyneins," and that "Tagged C11orf70 in Paramecium and Chlamydomonas localizes mainly in the cytoplasm with a small amount in the ciliary component."

PMID: 42067934 — Cfap300 regulates the transdifferentiation of Corpuscle of Stannius cells in zebrafish. Demonstrated cfap300 expression in ciliated organs — "cfap300 mRNA is highly expressed in the zebrafish pronephros" — but found that knockout zebrafish develop normally. This may reflect genetic compensation or species-specific differences. The unexpected non-ciliary phenotype (CS cell transdifferentiation) is intriguing but does not bear directly on the dynein assembly hypothesis.

Contextual References (DNAAF Pathway Mechanisms)

PMID: 35178554 — Characterized SPAG1 as an R2TP scaffold for dynein heavy chain assembly. This paper demonstrates the scaffold/co-chaperone paradigm that CFAP300 does not fit, as SPAG1 interacts with R2TP components and dynein chains while CFAP300 was not found in its interactome.

PMID: 30428028 — Defined WDR92's role linking R2TP to multiple DNAAFs in Chlamydomonas. Again, CFAP300 was not identified in WDR92 IP-MS experiments, suggesting it operates outside the R2TP network.

PMID: 18852297, PMID: 39880089 — Established and refined the ODA16 cargo adaptor model, where ODA16 bridges ODA to IFT-B via IFT46 and is released by Arl3. This provides the clearest comparison for a CFAP300 adaptor model, but the two proteins differ in every measurable parameter: fold, IFT complex partner, and cargo specificity.

PMID: 30561330, PMID: 33263282 — Discovered and characterized DynAP biomolecular condensates as the cytoplasmic site of dynein preassembly. These findings provide a cell biological framework within which CFAP300 likely operates, though its specific relationship to DynAPs has not been tested.

PMID: 37712517 — Reviewed intrinsically disordered regions of DNAAFs and their role in phase separation, providing context for CFAP300's aromatic content and disorder features.

Conflicts and Alternatives

Scaffold vs. Adaptor vs. Chaperone — Cannot Be Resolved

The hypothesis groups "scaffold/adaptor or chaperone" as alternatives to protein binding, but these are mechanistically distinct:

• Scaffold: Brings multiple components together simultaneously (like SPAG1 in R2TP)
• Adaptor: Bridges exactly two specific partners (like ODA16 bridging ODA and IFT46)
• Chaperone/co-chaperone: Assists protein folding/stabilization (like HSP90 in R2TP)

Current evidence cannot distinguish between these. The DNAAF2 + IFT139 dual interaction is consistent with adaptor or scaffold models, while the CCT3 interaction could hint at chaperone involvement. A "coupling factor" model that hands off assembled dyneins from preassembly to IFT is the best fit for the available data but remains speculative.

IFT-A vs. IFT-B Partnership

The canonical IFT cargo adaptor for dynein (ODA16) works through IFT-B via IFT46. CFAP300 interacts with IFT139, an IFT-A component. IFT-A is traditionally associated with retrograde transport and ciliary protein turnover, while IFT-B drives anterograde delivery. If the CFAP300-IFT139 interaction is genuine and functional, it would represent a novel IFT-A-dependent mechanism for dynein delivery. However, the interaction was shown in Paramecium and has not been validated in human cells.

Zebrafish Phenotype Discrepancy

Human CFAP300 mutations cause severe PCD, but zebrafish cfap300 knockouts develop normally (PMID: 42067934). This could reflect: (a) genetic compensation by paralogous DNAAFs in zebrafish, (b) species-specific differences in motile cilia dependence, (c) the analysis focused on specific phenotypes and may have missed subtle ciliary motility defects, or (d) the zebrafish study examined gross morphology rather than ciliary ultrastructure. This discrepancy warrants caution when making cross-species inferences.

No Paralog Confusion Risk

CFAP300 has no close paralogs in the human genome (PF14926 is a single-member family in humans). This reduces the risk of annotation transfer errors from paralogs, a common concern in GO curation.

HTP Interaction Artifacts

Of 10 reported CFAP300 interactions in databases, 8 are from high-throughput studies in non-ciliated cell lines (HEK293T, U2OS, HCT116) and are likely non-specific. Only the DNAAF2 (PMID: 29727693) and IFT139 (PMID: 29727692) interactions are from ciliary biology studies and should inform curation. Notably, the DNAAF2-CFAP300 interaction from PMID: 29727693 has NOT been deposited in IntAct, highlighting the importance of primary literature over database completeness.

Limitations and Knowledge Gaps

Gap 1: No Direct Biochemical Activity Data

What was checked: Sequence analysis, structural prediction (AlphaFold), domain searches (Pfam, InterPro, Foldseek), interaction databases (IntAct, BioGRID), and all primary literature. Why it matters: Without in vitro reconstitution or activity assays, it is impossible to assign a specific MF GO term beyond protein binding. The distinction between scaffold, adaptor, and chaperone mechanisms requires demonstration of direct molecular activity. What would resolve it: In vitro reconstitution of dynein preassembly with purified CFAP300; binding assays with defined dynein subunits; chaperone activity assays (e.g., prevention of aggregation, ATPase stimulation).

Gap 2: No Defined Dynein Client Specificity

What was checked: IP-MS data from reference papers, interaction databases. Why it matters: CFAP300 loss affects both ODA and IDA, but it is unknown whether CFAP300 directly contacts dynein heavy chains, intermediate chains, or both arm types. This determines whether it is a general assembly factor or has client specificity. What would resolve it: Crosslinking-MS of CFAP300 with dynein subcomplexes; identification of direct binding partners by reconstitution with purified components.

Gap 3: DynAP Localization Not Tested

What was checked: Literature on DynAP condensates (PMID: 30561330, PMID: 33263282); CFAP300 amino acid composition analysis showing elevated aromatics. Why it matters: If CFAP300 localizes to DynAPs, it would support the condensate framework and potentially reclassify its function. If it does not, the elevated aromatic content may be coincidental. What would resolve it: Fluorescently tagged CFAP300 imaging in multiciliated cells with DynAP markers (G3BP1, RUVBL1); FRAP analysis.

Gap 4: IFT139 Interaction Not Validated in Human Cells

What was checked: PMID: 29727692 (interaction shown in Paramecium). Why it matters: IFT139 is an IFT-A (retrograde) component, whereas the canonical dynein transport adaptor ODA16 uses IFT-B. If CFAP300 genuinely functions through IFT-A, this represents a novel mechanism. But species-specific interactions are possible. What would resolve it: Human cell co-IP or proximity labeling; live imaging of CFAP300 transport in cilia.

Gap 5: Role of Conserved Cysteines and DELR Motif

What was checked: Multiple sequence alignment of 7 CFAP300 orthologs; AlphaFold structure analysis of cysteine positions. Why it matters: Eight perfectly conserved cysteines (too far apart for intramolecular disulfides in the monomer) could mediate redox-sensitive interactions, zinc coordination in complex, or conformational changes upon partner binding. The deeply conserved DELR motif (positions 137–140) may represent a critical functional site. What would resolve it: Site-directed mutagenesis and phenotypic rescue; metal content analysis; co-crystallization with binding partners.

Gap 6: Relationship to R2TP/HSP90 Pathway Unknown

What was checked: Domain analysis (no PIH1, TPR, CS domains); absence from SPAG1 and WDR92 interactomes. Why it matters: Other DNAAFs work through R2TP; CFAP300's relationship is undefined. It could be upstream, downstream, or parallel to R2TP. What would resolve it: Test CFAP300 interaction with R2TP components (RUVBL1/2, RPAP3) and HSP90 in ciliated cells.

Discriminating Tests

Priority 1: Distinguish Preassembly vs. Transport Defect

1. Dynein subunit stability assay: In CFAP300-mutant cells, are dynein heavy chains (DNAH5, DNAH11) absent from the cytoplasm (preassembly defect) or present in cytoplasm but absent from cilia (transport defect)? Precedent: SPAG1 mutants show reduced cytoplasmic DHC levels (PMID: 35178554), indicating preassembly defect. If cytoplasmic DHCs are reduced: supports chaperone/scaffold role. If normal but ciliary import fails: supports IFT adaptor role.

2. In vitro dynein rebinding: Extract dyneins from wild-type axonemes and test rebinding to CFAP300-mutant axonemes. If rebinding succeeds, the defect is in transport/preassembly, not docking site formation (following ODA16 precedent, PMID: 18852297).

Priority 2: Define Complete Interaction Network

1. BioID/TurboID proximity labeling in differentiated human airway epithelial cells expressing tagged CFAP300. This would comprehensively identify proximal proteins in the native cellular context, including dynein clients and assembly co-factors. This single experiment would be the most informative for distinguishing scaffold (many stable contacts), adaptor (bridging two defined complexes), and chaperone (transient client interactions) models.

2. AlphaFold-Multimer predictions of CFAP300 with DNAAF2, IFT139, and candidate dynein subunits. This computational approach could predict binding interfaces and guide mutagenesis.

Priority 3: Resolve DynAP and Condensate Roles

1. CFAP300 DynAP co-localization in multiciliated cells using established markers. This would determine whether CFAP300 partitions into condensates, supporting the elevated aromatic content observations.

2. Quantitative proteomics of CFAP300-mutant versus wild-type ciliated cells. This would reveal which dynein subunits and assembly intermediates are affected, distinguishing specific client relationships from general assembly failure.

Curation Leads

Lead 1: Add GO:0070286 (axonemal dynein complex assembly) — HIGH PRIORITY

• Action: Add BP annotation with qualifier "involved_in"
• Evidence code: IMP (inferred from mutant phenotype)
• References: PMID: 29727692, PMID: 29727693
• Verification snippet (29727693): "Furthermore, C11orf70 shows an interaction with cytoplasmic ODA/IDA assembly factor DNAAF2, supporting our hypothesis that C11orf70 is a preassembly factor involved in the pathogenesis of PCD."
• Verification snippet (29727692): "Phylogenetic analysis shows C11orf70 is highly conserved, distributed across species similarly to proteins involved in the intraflagellar transport (IFT)-dependant assembly of axonemal dyneins."
• Confidence: High — multiple PCD families, cross-species RNAi validation, consistent with DNAAF family classification

Lead 2: Add GO:0036158 and GO:0036159 (ODA and IDA Assembly) — MODERATE PRIORITY

• Action: Add more specific BP child terms
• Evidence code: IMP
• References: PMID: 29727692, PMID: 29727693
• Rationale: Both ODA and IDA are absent from axonemes in CFAP300-mutant cilia. Other DNAAFs (ZMYND10, DNAAF11) carry these more specific terms.

Lead 3: Retain GO:0005515 (Protein Binding) — No Change

• Action: Retain current MF annotation; do not replace with scaffold/adaptor/chaperone
• Rationale: The hypothesis correctly identifies this as uninformative, but no experimental evidence supports a more specific MF term. The BP annotation (GO:0070286) better captures CFAP300's biological role and should be the priority addition.
• Future consideration: If proximity labeling identifies specific dynein chain clients, consider GO:0045504 (dynein heavy chain binding) or GO:0060090 (molecular adaptor activity).

Lead 4: Consider GO:0120293 (Dynein Axonemal Particle) — LOW-MODERATE PRIORITY

• Action: Evaluate CC annotation for DynAP with ISS/IBA evidence
• Rationale: CFAP300 interacts with DNAAF2 (a DynAP component) and has compositional features consistent with condensate partitioning. Direct demonstration pending.

Lead 5: Hypothesis Refinement for Future Work

• The seed hypothesis should be narrowed for future investigation. Rather than "scaffold/adaptor or chaperone," specific testable models should be:
• IFT cargo coupling factor (bridging preassembled dynein to IFT-A for ciliary import) — favored by dual DNAAF2+IFT139 interaction
• DynAP scaffold (organizing dynein preassembly within cytoplasmic condensates) — consistent with aromatic content
• Novel co-chaperone (assisting dynein assembly through non-R2TP mechanism) — least supported by current data

Suggested Questions for Curator Review

1. Should GO:0070286 be annotated with IMP from both 29727692 and 29727693, or is one reference sufficient?
2. Is the zebrafish data (PMID: 42067934) showing normal development relevant to the human-based PCD annotations, and should it be noted?
3. Does the DNAAF2 interaction from PMID: 29727693 need to be deposited in IntAct to support curation, or is the primary literature sufficient?
4. Should the protein-binding MF annotation be flagged with a curator note indicating it is a placeholder pending biochemical characterization?